Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://susanrxuj593107.glifeblog.com/37689764/trelaglutide-exploring-a-new-option-for-chronic-diseases